0000897069-24-001611.txt : 20240802 0000897069-24-001611.hdr.sgml : 20240802 20240802172843 ACCESSION NUMBER: 0000897069-24-001611 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20240405 FILED AS OF DATE: 20240802 DATE AS OF CHANGE: 20240802 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Lin Patrick CENTRAL INDEX KEY: 0001799363 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39531 FILM NUMBER: 241172404 MAIL ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Processa Pharmaceuticals, Inc. CENTRAL INDEX KEY: 0001533743 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 451539785 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 BUSINESS PHONE: 443-776-3133 MAIL ADDRESS: STREET 1: 7380 COCA COLA DRIVE STREET 2: SUITE 106 CITY: HANOVER STATE: MD ZIP: 21076 FORMER COMPANY: FORMER CONFORMED NAME: Heatwurx, Inc. DATE OF NAME CHANGE: 20111028 4 1 form4.xml X0508 4 2024-04-05 0001533743 Processa Pharmaceuticals, Inc. PCSA 0001799363 Lin Patrick C/O PROCESSA PHARMACEUTICALS, INC. 7380 COCA COLA DRIVE, SUITE 106 HANOVER MD 21076 true Chief Business - Strategy Off false Common Stock 2024-04-05 4 M 0 1675 A 29225 D Common Stock 2024-04-05 4 F 0 539 2.79 D 28686 D Common Stock 2024-07-10 4 M 0 644 A 29330 D Common Stock 2024-07-10 4 F 0 271 1.71 D 29059 D Restricted Stock Units 0 2024-06-28 4 A 0 2713 0 A Common Stock 2713 22201 D Restricted Stock Units 0 2024-06-28 4 A 0 2035 0 A Common Stock 2035 24236 D Restricted Stock Units 0 2024-06-28 4 A 0 339 0 A Common Stock 339 24575 D Restricted Stock Units 0 2024-06-28 4 A 0 339 0 A Common Stock 339 24914 D Distribution of vested restricted shares. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on January 1, 2025. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting on of one-third on January 1, 2025, and one-thirty-sixth each month thereafter until fully vested on January 1, 2027. Each Restricted Stock Unit represents a contingent right to receive one share of the Issuer's common stock, following its vesting upon the achievement of certain performance goals. /s/ Patrick Lin by Michael B. Kirwan, as Attorney-in-Fact 2024-08-02